{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:16:06Z","timestamp":1790086566071,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T00:00:00Z","timestamp":1439942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T00:00:00Z","timestamp":1439942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Semant"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vaccines are one of the most important public health successes in last century. Besides effectiveness in reducing the morbidity and mortality from many infectious diseases, a successful vaccine program also requires a rigorous assessment on their safety. Due to the limitations of adverse event (AE) data from clinical trials and post-approval surveillance systems, novel computational approaches are needed to organize, visualize, and analyze such high-dimensional complex data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this paper, we proposed a network-based approach to investigate the vaccine-AE association network from the Vaccine AE Reporting System (VAERS) data. Statistical summary was calculated using the VAERS raw data and represented in the Resource Description Framework (RDF). The RDF graph was leveraged for network analysis. Specifically, we compared network properties of (1) vaccine - adverse event association network based on reports collected over a 23 year period as well as each year; and (2) sex-specific vaccine-adverse event association network. We observed that (1) network diameter and average path length don\u2019t change dramatically over a 23-year period, while the average node degree of these networks changes due to the different number of reports during different periods of time; (2) vaccine - adverse event associations derived from different sexes show sex-associated patterns in sex-specific vaccine-AE association networks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We have developed a network-based approach to investigate the vaccine-AE association network from the VAERS data. To our knowledge, this is the first time that a network-based approach was used to identify sex-specific association patterns in a spontaneous reporting system database. Due to unique limitations of such passive surveillance systems, our proposed network-based approaches have the potential to summarize and analyze the associations in passive surveillance systems by (1) identifying nodes of importance, irrespective of whether they are disproportionally reported; (2) providing guidance on sex-specific recommendations in personalized vaccinology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13326-015-0032-2","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T08:21:26Z","timestamp":1439886086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of sex-associated network patterns in Vaccine-Adverse Event Association Network in VAERS"],"prefix":"10.1186","volume":"6","author":[{"given":"Yuji","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,19]]},"reference":[{"issue":"52","key":"32_CR1","doi-asserted-by":"publisher","first-page":"8227","DOI":"10.1016\/j.vaccine.2010.11.001","volume":"28","author":"GA Poland","year":"2010","unstructured":"Poland GA, Levine MM, Clemens JD. Developing the next generation of vaccinologists. Vaccine. 2010;28(52):8227\u20138.","journal-title":"Vaccine"},{"key":"32_CR2","unstructured":"The U.S. FDA\/CDC Vaccine Adverse Event Reporting System (VAERS) [http:\/\/vaers.hhs.gov\/index]"},{"issue":"9","key":"32_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/pds.1107","volume":"14","author":"D Banks","year":"2005","unstructured":"Banks D, Woo EJ, Burwen DR, Perucci P, Braun MM, Ball R. Comparing data mining methods on the VAERS database. Pharmacoepidemiol Drug Saf. 2005;14(9):601\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"32_CR4","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/clpt.2012.50","volume":"91","author":"R Harpaz","year":"2012","unstructured":"Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther. 2012;91(6):1010\u201321.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"32_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pds.1742","volume":"18","author":"A Bate","year":"2009","unstructured":"Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18(6):427\u201336.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"32_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/clpt.2010.285","volume":"89","author":"R Harpaz","year":"2011","unstructured":"Harpaz R, Perez H, Chase HS, Rabadan R, Hripcsak G, Friedman C. Biclustering of adverse drug events in the FDA's spontaneous reporting system. Clin Pharmacol Ther. 2011;89(2):243\u201350.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"32_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/clpt.2010.91","volume":"88","author":"DK Arrell","year":"2010","unstructured":"Arrell DK, Terzic A. Network systems biology for drug discovery. Clin Pharmacol Ther. 2010;88(1):120\u20135.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"32_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/bib\/bbr013","volume":"12","author":"JT Dudley","year":"2011","unstructured":"Dudley JT, Deshpande T, Butte AJ. Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinfo. 2011;12(4):303\u201311.","journal-title":"Brief Bioinfo"},{"issue":"5","key":"32_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1742-4658.2012.08471.x","volume":"279","author":"RM Piro","year":"2012","unstructured":"Piro RM, Di Cunto F. Computational approaches to disease-gene prediction: rationale, classification and successes. Febs J. 2012;279(5):678\u201396.","journal-title":"Febs J"},{"issue":"4","key":"32_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ajhg.2008.02.013","volume":"82","author":"S Kohler","year":"2008","unstructured":"Kohler S, Bauer S, Horn D, Robinson PN. Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet. 2008;82(4):949\u201358.","journal-title":"Am J Hum Genet"},{"key":"32_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2105-10-73","volume":"10","author":"J Chen","year":"2009","unstructured":"Chen J, Aronow BJ, Jegga AG. Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinfo. 2009;10:73.","journal-title":"BMC Bioinfo"},{"issue":"21","key":"32_CR12","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.1073\/pnas.0701361104","volume":"104","author":"KI Goh","year":"2007","unstructured":"Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. P Natl Acad Sci USA. 2007;104(21):8685\u201390.","journal-title":"P Natl Acad Sci USA"},{"issue":"2","key":"32_CR13","doi-asserted-by":"publisher","first-page":"e1000662","DOI":"10.1371\/journal.pcbi.1000662","volume":"6","author":"S Suthram","year":"2010","unstructured":"Suthram S, Dudley JT, Chiang AP, Chen R, Hastie TJ, Butte AJ. Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol. 2010;6(2):e1000662.","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"32_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/clpt.2011.119","volume":"90","author":"R Ball","year":"2011","unstructured":"Ball R, Botsis T. Can network analysis improve pattern recognition among adverse events following immunization reported to VAERS? Clin Pharmacol Ther. 2011;90(2):271\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"32_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2041-1480-4-33","volume":"4","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Tao C, He Y, Kanjamala P, Liu H. Network-based analysis of vaccine-related associations reveals consistent knowledge with the vaccine ontology. J Biomed Semantics. 2013;4(1):33.","journal-title":"J Biomed Semantics"},{"issue":"8","key":"32_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004;13(8):519\u201323.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"32_CR17","doi-asserted-by":"crossref","unstructured":"Tao C, Wu P, Zhang Y: Linked Vaccine Adverse Event Data Representation from VAERS for Biomedical Informatics Research. 18th Pacific-Asia Conference on Knowledge Discovery and Data Mining (PAKDD 2014): 2014; Tainan, Taiwan","DOI":"10.1007\/978-3-319-13186-3_58"},{"issue":"3","key":"32_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformat. 2011;27(3):431\u20132.","journal-title":"Bioinformat"},{"issue":"12","key":"32_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/nmeth.2728","volume":"10","author":"JI Fuxman Bass","year":"2013","unstructured":"Fuxman Bass JI, Diallo A, Nelson J, Soto JM, Myers CL, Walhout AJ. Using networks to measure similarity between genes: association index selection. Nat Methods. 2013;10(12):1169\u201376.","journal-title":"Nat Methods"},{"key":"32_CR20","unstructured":"Zhou F. Updated economic evaluation of the routine childhood immunization schedule in the United State. In: 45th National Immunization Conference; Washington DC. 2011."},{"issue":"5","key":"32_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/INF.0b013e3181a6a511","volume":"28","author":"GA Poland","year":"2009","unstructured":"Poland GA, Ovsyannikova IG, Jacobson RM. Adversomics: the emerging field of vaccine adverse event immunogenetics. Pediatr Infect Dis J. 2009;28(5):431\u20132.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"32_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.bjc.6603575","volume":"96","author":"KM French","year":"2007","unstructured":"French KM, Barnabas RV, Lehtinen M, Kontula O, Pukkala E, Dillner J, et al. Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland. Br J Cancer. 2007;96(3):514\u20138.","journal-title":"Br J Cancer"},{"issue":"9376","key":"32_CR23","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(03)13771-3","volume":"361","author":"P Aaby","year":"2003","unstructured":"Aaby P, Jensen H, Samb B, Cisse B, Sodemann M, Jakobsen M, et al. Differences in female\u2013male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet. 2003;361(9376):2183\u20138.","journal-title":"Lancet"},{"key":"32_CR24","doi-asserted-by":"crossref","unstructured":"Tao C, Zhang Y, Jiang G, Bouamrane M-M, Chute CG: Optimizing semantic MEDLINE for translational science studies using semantic web technologies. Proceedings of the 2nd international workshop on Managing interoperability and compleXity in health systems; Maui, Hawaii, USA. 2389683: ACM 2012: 53\u201358.","DOI":"10.1145\/2389672.2389683"}],"container-title":["Journal of Biomedical Semantics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13326-015-0032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13326-015-0032-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13326-015-0032-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13326-015-0032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:27:49Z","timestamp":1790036869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13326-015-0032-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,19]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1186\/s13326-015-0032-2","relation":{},"ISSN":["2041-1480"],"issn-type":[{"value":"2041-1480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,19]]},"assertion":[{"value":"10 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}